Teva says higher dose of MS drug no more efficient (Reuters)Reuters - Teva Pharmaceutical Industries Ltd said data
from a late-stage trial showed an increased dose of its
multiple sclerosis drug, glatiramer acetate (GA), was not more
efficient than an approved lower-dose version of the drug.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/teva_drug_dc.html